Pemazyre
Manufacturing · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.pemazyre.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Pemazyre
PEMAZYRE is a prescription medicine designed specifically for the treatment of adults with bile duct cancer (cholangiocarcinoma) that has spread or is inoperable. It is used for patients who have undergone previous treatment and whose tumors have an abnormal 'FGFR2' gene. The company emphasizes the importance of genetic testing to ensure that PEMAZYRE is suitable for each patient. PEMAZYRE is not classified as chemotherapy; it is a targeted therapy approved based on tumor response and duration of response.Explore more
Popular SearchesPemazyreIncyte CorpSIC Code 28,283NAICS Code 32,325Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Pemazyre your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Pemazyre is spiking on competitors!
Check if Pemazyre has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Pemazyre launches new products
Funding: Get notified immidiatlly once Pemazyre has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Pemazyre recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Pemazyre
Website visits: Recent activity has been detected on your website
Pemazyre, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Pemazyre had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Pemazyre
Find 2 more new buyers
Compare Similar Companies to Pemazyre
Compare insights from companies similar to Pemazyre, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Pemazyre
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
Pemazyre is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Pemazyre is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Pemazyre.
Pemazyre Tech Stack
A closer look at the technologies used by Pemazyre
See more technologies
Pemazyre News & Media
Incyte Announces Health Canada Conditional Approval of Pemazyre® (pemigatinib) as First ...
/CNW/ - Incyte (NASDAQ: INCY) today announced that Health Canada has granted a Notice of Compliance with conditions for Pemazyre® (pemigatinib), a selective...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Pemazyre
Sign Up For FreeTo access detailed company insights
PEMAZYRE is a prescription medicine designed specifically for the treatment of adults with bile duct cancer (cholangiocarcinoma) that has spread or is inoperable. It is used for patients who have undergone previous treatment and whose tumors have an abnormal 'FGFR2' gene. The company emphasizes the importance of genetic testing to ensure that PEMAZ... Read More
